Clinical Trial Update: Comparison of In-House Methods and Cobas BRAF V600 Mutation Assay in Melanoma Tumor Samples

View source ↗

Summary

A completed clinical trial compared in-house methods against the Cobas BRAF V600 mutation assay for detecting BRAF V600 mutations in melanoma tumor samples, wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Malignant Melanoma | Status: COMPLETED | Results posted: 2016-03-28